Nigel McCracken
Chief Operating Officer bei VIRAX BIOLABS GROUP LIMITED
Aktive Positionen von Nigel McCracken
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIRAX BIOLABS GROUP LIMITED | Chief Operating Officer | 01.09.2023 | - |
Karriereverlauf von Nigel McCracken
Ehemalige bekannte Positionen von Nigel McCracken
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BERGENBIO ASA | Chief Tech/Sci/R&D Officer | 01.01.2021 | 01.09.2023 |
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Director/Board Member | 01.09.2014 | 01.04.2019 |
Corporate Officer/Principal | 01.09.2014 | 01.04.2019 | |
NUCANA PLC | Chief Operating Officer | - | - |
Ausbildung von Nigel McCracken
University of Strathclyde | Undergraduate Degree |
King's College London | Graduate Degree |
Statistik
International
Vereinigtes Königreich | 5 |
Schweiz | 2 |
Norwegen | 2 |
Operativ
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Director/Board Member | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BERGENBIO ASA | Health Technology |
NUCANA PLC | Health Technology |
VIRAX BIOLABS GROUP LIMITED | Finance |
Private Unternehmen | 1 |
---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Börse
- Insiders
- Nigel McCracken
- Erfahrung